Stressing the stem cell in acute myeloid leukemia von Borthakur, Gautam

Volltext

Core binding factor acute myelogenous leukemia-2021 treatment algorithm von Borthakur, Gautam, Kantarjian, Hagop

Volltext

Acute myeloid leukemia: current progress and future directions von Kantarjian, Hagop, Kadia, Tapan, DiNardo, Courtney, Daver, Naval, Borthakur, Gautam, Jabbour, Elias, Garcia-Manero, Guillermo, Konopleva, Marina, Ravandi, Farhad

Volltext

De novo acute myeloid leukemia: A population‐based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017 von Sasaki, Koji, Ravandi, Farhad, Kadia, Tapan M., DiNardo, Courtney D., Short, Nicholas J., Borthakur, Gautam, Jabbour, Elias, Kantarjian, Hagop M.

Volltext

Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges von Short, Nicholas J, Konopleva, Marina, Kadia, Tapan M, Borthakur, Gautam, Ravandi, Farhad, DiNardo, Courtney D, Daver, Naval

Volltext

Ibrutinib and Venetoclax for First-Line Treatment of CLL von Jain, Nitin, Keating, Michael, Thompson, Philip, Ferrajoli, Alessandra, Burger, Jan, Borthakur, Gautam, Takahashi, Koichi, Estrov, Zeev, Fowler, Nathan, Kadia, Tapan, Konopleva, Marina, Alvarado, Yesid, Yilmaz, Musa, DiNardo, Courtney, Bose, Prithviraj, Ohanian, Maro, Pemmaraju, Naveen, Jabbour, Elias, Sasaki, Koji, Kanagal-Shamanna, Rashmi, Patel, Keyur, Jorgensen, Jeffrey, Garg, Naveen, Wang, Xuemei, Sondermann, Katrina, Cruz, Nichole, Wei, Chongjuan, Ayala, Ana, Plunkett, William, Kantarjian, Hagop, Gandhi, Varsha, Wierda, William

Volltext

Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials von Atkins, Johnique T., George, Goldy C., Hess, Kenneth, Marcelo-Lewis, Kathrina L., Yuan, Ying, Borthakur, Gautam, Khozin, Sean, LoRusso, Patricia, Hong, David S.

Volltext

Phase I Study of Quizartinib Administered Daily to Patients With Relapsed or Refractory Acute Myeloid Leukemia Irrespective of FMS-Like Tyrosine Kinase 3–Internal Tandem Duplicatio... von CORTES, Jorge E, KANTARJIAN, Hagop, LEVIS, Mark, FORAN, James M, GHIRDALADZE, Darejan, ZODELAVA, Mamia, BORTHAKUR, Gautam, GAMMON, Guy, TRONE, Denise, ARMSTRONG, Robert C, JAMES, Joyce

Volltext

Long‐term follow‐up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic‐phase chronic myeloid leukemia von Naqvi, Kiran, Jabbour, Elias, Skinner, Jeffrey, Anderson, Kristin, Dellasala, Sara, Yilmaz, Musa, Ferrajoli, Alessandra, Bose, Prithviraj, Thompson, Philip, Alvarado, Yesid, Jain, Nitin, Takahashi, Koichi, Burger, Jan, Estrov, Zeev, Borthakur, Gautam, Pemmaraju, Naveen, Paul, Shilpa, Cortes, Jorge, Kantarjian, Hagop M.

Volltext

Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality von Ishizawa, Jo, Zarabi, Sarah F., Davis, R. Eric, Halgas, Ondrej, Nii, Takenobu, Jitkova, Yulia, Zhao, Ran, St-Germain, Jonathan, Heese, Lauren E., Egan, Grace, Ruvolo, Vivian R., Barghout, Samir H., Nishida, Yuki, Hurren, Rose, Ma, Wencai, Gronda, Marcela, Link, Todd, Wong, Keith, Mabanglo, Mark, Kojima, Kensuke, Borthakur, Gautam, MacLean, Neil, Ma, Man Chun John, Leber, Andrew B., Minden, Mark D., Houry, Walid, Kantarjian, Hagop, Stogniew, Martin, Raught, Brian, Pai, Emil F., Schimmer, Aaron D., Andreeff, Michael

Volltext

Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leuke... von Daver, Naval, Thomas, Deborah, Ravandi, Farhad, Cortes, Jorge, Garris, Rebecca, Jabbour, Elias, Garcia-Manero, Guillermo, Borthakur, Gautam, Kadia, Tapan, Rytting, Michael, Konopleva, Marina, Kantarjian, Hagop, O'Brien, Susan

Volltext

TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes von Kadia, Tapan M., Jain, Preetesh, Ravandi, Farhad, Garcia‐Manero, Guillermo, Andreef, Michael, Takahashi, Koichi, Borthakur, Gautam, Jabbour, Elias, Konopleva, Marina, Daver, Naval G., Dinardo, Courtney, Pierce, Sherry, Kanagal‐Shamanna, Rashmi, Patel, Keyur, Estrov, Zeev, Cortes, Jorge, Kantarjian, Hagop M.

Volltext

Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy von Venugopal, Sangeetha, Takahashi, Koichi, Daver, Naval, Maiti, Abhishek, Borthakur, Gautam, Loghavi, Sanam, Short, Nicholas. J., Ohanian, Maro, Masarova, Lucia, Issa, Ghayas, Wang, Xuemei, Carlos, Bueso-Ramos, Yilmaz, Musa, Kadia, Tapan, Andreeff, Michael, Ravandi, Farhad, Konopleva, Marina, Kantarjian, Hagop M., DiNardo, Courtney D.

Volltext

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms von Zhang, Haijiao, Savage, Samantha, Schultz, Anna Reister, Bottomly, Daniel, White, Libbey, Segerdell, Erik, Wilmot, Beth, McWeeney, Shannon K., Eide, Christopher A., Nechiporuk, Tamilla, Carlos, Amy, Henson, Rachel, Lin, Chenwei, Searles, Robert, Ho, Hoang, Lam, Yee Ling, Sweat, Richard, Follit, Courtney, Jain, Vinay, Lind, Evan, Borthakur, Gautam, Garcia-Manero, Guillermo, Ravandi, Farhad, Kantarjian, Hagop M., Cortes, Jorge, Collins, Robert, Buelow, Daelynn R., Baker, Sharyn D., Druker, Brian J., Tyner, Jeffrey W.

Volltext

Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN von Jabbour, Elias, Short, Nicholas J., Montalban-Bravo, Guillermo, Huang, Xuelin, Bueso-Ramos, Carlos, Qiao, Wei, Yang, Hui, Zhao, Chong, Kadia, Tapan, Borthakur, Gautam, Pemmaraju, Naveen, Sasaki, Koji, Estrov, Zeev, Cortes, Jorge, Ravandi, Farhad, Alvarado, Yesid, Komrokji, Rami, Sekeres, Mikkael A., Steensma, David P., DeZern, Amy, Roboz, Gail, Kantarjian, Hagop, Garcia-Manero, Guillermo

Volltext

Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment von WALTER, Roland B, OTHUS, Megan, BORTHAKUR, Gautam, RAVANDI, Farhad, CORTES, Jorge E, PIERCE, Sherry A, APPELBAUM, Frederick R, KANTARJIAN, Hagop A, ESTEY, Elihu H

Volltext

Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia von Pan, Rongqing, Hogdal, Leah J, Benito, Juliana M, Bucci, Donna, Han, Lina, Borthakur, Gautam, Cortes, Jorge, DeAngelo, Daniel J, Debose, Lakeisha, Mu, Hong, Döhner, Hartmut, Gaidzik, Verena I, Galinsky, Ilene, Golfman, Leonard S, Haferlach, Torsten, Harutyunyan, Karine G, Hu, Jianhua, Leverson, Joel D, Marcucci, Guido, Müschen, Markus, Newman, Rachel, Park, Eugene, Ruvolo, Peter P, Ruvolo, Vivian, Ryan, Jeremy, Schindela, Sonja, Zweidler-McKay, Patrick, Stone, Richard M, Kantarjian, Hagop, Andreeff, Michael, Konopleva, Marina, Letai, Anthony G

Volltext

The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia von Alfayez, Mansour, Issa, Ghayas C., Patel, Keyur P., Wang, Feng, Wang, Xuemei, Short, Nicholas J., Cortes, Jorge E., Kadia, Tapan, Ravandi, Farhad, Pierce, Sherry, Assi, Rita, Garcia-Manero, Guillermo, DiNardo, Courtney D., Daver, Naval, Pemmaraju, Naveen, Kantarjian, Hagop, Borthakur, Gautam

Volltext

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience von Kantarjian, Hagop, O'Brien, Susan, Jabbour, Elias, Garcia-Manero, Guillermo, Quintas-Cardama, Alfonso, Shan, Jenny, Rios, Mary Beth, Ravandi, Farhad, Faderl, Stefan, Kadia, Tapan, Borthakur, Gautam, Huang, Xuelin, Champlin, Richard, Talpaz, Moshe, Cortes, Jorge

Volltext

Hypomethylating agent and venetoclax with FLT3 inhibitor “triplet” therapy in older/unfit patients with FLT3 mutated AML von Yilmaz, Musa, Kantarjian, Hagop, Short, Nicholas J., Reville, Patrick, Konopleva, Marina, Kadia, Tapan, DiNardo, Courtney, Borthakur, Gautam, Pemmaraju, Naveen, Maiti, Abhishek, Jabbour, Elias, Jain, Nitin, Issa, Ghayas, Takahashi, Koichi, Sasaki, Koji, Ohanian, Maro, Pierce, Sherry, Tang, Guillin, Loghavi, Sanam, Patel, Keyur, Wang, Sa A., Garcia-Manero, Guillermo, Andreeff, Michael, Ravandi, Farhad, Daver, Naval

Volltext